-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GMVSDBd87xLDDaIX09M2wWAsKrIR+nCDd75Fz9Os63z3uodu3SXOP9uEOlCBhxaE xmjS3MWiJdsM6Llr1X99dQ== 0000946644-03-000020.txt : 20030912 0000946644-03-000020.hdr.sgml : 20030912 20030912150739 ACCESSION NUMBER: 0000946644-03-000020 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030911 ITEM INFORMATION: Other events FILED AS OF DATE: 20030912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13441 FILM NUMBER: 03893784 BUSINESS ADDRESS: STREET 1: 1617 JFK BLVD #660 STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 2159880080 MAIL ADDRESS: STREET 1: 1617 JFK BLVD STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 8-K 1 r8k_91103.txt FORM 8K HEMISPHERX BIOPHARMA, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report - September 12, 2003 (Date of earliest event reported) Hemispherx Biopharma, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27072 52-0845822 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification Number) 1617 JFK Boulevard 19103 (Address of principal executive offices) (Zip Code) Area Code (215) 988-0080 (Registrant's telephone number 1 Item 5. Other Events At the Company's Annual Meeting of Stockholders on September 10, 2003, stockholders approved the following: Total shares voted: 27,003,653 out of 35,821,275 eligible to vote. Election of Directors: For Withheld William A. Carter, M.D. 22,344,867 4,658,786 Richard C. Piani, Esq. 24,899,018 2,104,635 Ransom W. Etheridge, Esq. 22,942,478 4,061,175 William M. Mitchell. Ph.D., M.D. 23,903,718 3,099,935 Iraj-Eqhbal Kiani, Ph.D. 24,269,933 2,733,720 Ratification of the selection of BDO Seidman, LLP, as independent auditors of Hemispherx Biopharma, Inc. for the year ending December 31, 2003. For: 25,033,555 Against: 1,960,625 Abstain: 9,473 Amend the Company's Certificate of Incorporation to increase the authorized shares of common stock from 50,000,000 to 100,000,000. For: 24,695,036 Against: 2,298,867 Abstain: 9,750 -----END PRIVACY-ENHANCED MESSAGE-----